Top Stories News
Top Stories news
-
News Big pharma collaborate to speed up drug development
TransCelerate BioPharma is a non-profit organisation set up by ten biopharmaceutical giants. -
News Cardiolynx Receives Patent on Improved Angina Pectoris Drug
Cardiolynx Ltd., specializing in the development of improved cardio-metabolic therapies, announces that the European Patent Office (EPO) has granted a patent covering a new chemical entity, CLC-1280, developed using Cardiolynx' nitric oxide technology. -
News Mucosis Appoints Thomas Johnston to CEO
Mucosis B.V., the Dutch clinical-stage biotechnology company developing mucosal vaccines, today announced the appointment of Thomas Johnston to the position of Chief Executive Officer, effective immediately. -
News RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human)
The European Medicines Agency has been formally notified by RepliGen Europe Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine SecreFlo (secretin human). -
News Committee for Orphan Medicinal Products elects new chair and vice-chair
At its September 2012 meeting, the European Medicines Agency's Committee for Orphan Medicinal Products (COMP) elected Professor Bruno Sepodes from Portugal as its chair and Ms Lesley Greene, a volunteer patient representative for Eurordis, as its vice-... -
News European Medicines Agency clarifies rules on fees
The European Medicines Agency has revised the rules on fees payable to the Agency. -
News Stella Blackburn appointed president of the International Society for Pharmacoepidemiology
The European Medicines Agency congratulates Dr Stella Blackburn, the Agency's Risk Management Development and Scientific Lead, for her appointment as president of the International Society for Pharmacoepidemiology (ISPE). -
News Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair
The European Medicines Agencys recently established Pharmacovigilance Risk Assessment Committee (PRAC) has elected June Raine (pictured) from the United Kingdom (UK) as its chair and álmath Spooner from Ireland as its vice-chair at its second mee... -
News Big Pharma Fights Drug Rulings In India
Landmark drug patent protection cases involving Bayer, Roche, and Novartis are advancing in India this month. Together, they will help determine how friendly the country is to Western pharmaceutical makers. -
News AESICA ANNOUNCES KEY NORTH AMERICAN APPOINTMENT
One of Europes leading CMOs, Aesica, has announced a key addition to its commercial team as it looks to strengthen its position in North America. -
News Possible therapy for tamoxifen-resistant breast cancer identified
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. -
News Pfizer leukaemia drug receives US approval
The US Food and Drug Administration has approved Pfizer's Bosulif, used to treat a rare type of leukaemia usually suffered by older adults. -
News FDA questions efficacy of Novartis cystic fibrosis drug tobramycin
The US Food and Drug Administration has questioned the efficacy of Novartis' experimental cystic fibrosis drug tobramycin ahead of an advisory panel meeting this week. -
News Biotage Unveils New Fully Automated Microwave Peptide Synthesizer
Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, introduced an innovative new synthesis platform for peptide researchers at the 2012 European Peptide Symposium in Athens, Greece... -
News Majority of pharma firms have in-house companion diagnostics staff
Many companies now have people working full-time on companion diagnostics for use alongside targeted therapies. -
News Pfizer and Mylan announce generics collaboration in Japan
A new partnership between Pfizer and Mylan should help to drive generic utilisation in Japan. -
News Pharma companies spend over $30m on global MSL teams
Cutting Edge Information has shed light on pharmaceutical companies' MSL spend. -
News Peru's Pharmaceutical Exports to Exceed $50M in 2012
The president of Peru's pharmaceutical industry association has predicted that exports will surpass $50 million this year. -
News Generics Save Consumers Billions of Pounds
Consumers and national healthcare systems make significant savings as a result of generic medicines usage, a report has confirmed. -
News Saladax Expands Relationship with BMS
Saladax Biomedical has expanded its existing relationship with Bristol-Myers Squibb by entering into a Master Early Development Collaboration Agreement. -
News Gilead to Collaborate with Indian Partners on Generic Versions of Emtricitabine
Gilead and its partners in India aim to improve access to affordable antiretroviral therapy for HIV patients in developing countries. -
News Study Says Generic Medications Saved $1 Trillion over the Last Decade
The American health care system saved more than $1 trillion through the use of generic medicines over the last decade. -
News Patent Expirations Hit Irish Pharma Exports to US
The end of patent protection has hit Irish pharmaceutical exports to the US in the first half of the year, new figures show. -
News Suzhou Connect Enters Licensing Agreement with Arena
Suzhou Connect hopes to advance novel small molecule compounds for the treatment of allergic rhinitis and atopic dermatitis. -
News Merck Serono Announces Creation of Prexton
The newly founded company will develop the mGluR programs from lead optimization up to clinical Phase I and seek partnership and licensing opportunities for further development. -
News 'Organs-on-chips' to Accelerate Drug Candidate Assessment
Harvard scientists hope to develop a unique instrument that will help drug developers to assess new drug candidates. -
News Pharma Industry Has 'Significant Pipeline' of New Obesity Treatments
Many leading pharmaceutical companies are working on new treatments for obesity and diabetes, according to a new Medmeme report. -
News Majority of Pharmaceutical Companies 'Worried about Disaster Recovery'
Health and pharmaceutical companies need to pay more attention to their backup and disaster recovery plans, a survey suggests. -
News Merck Signs Deals for Novel HIV Drug Candidates
Merck has signed licensing agreements with Chimerix Inc and Yamasa Corporation for two investigational HIV drug candidates. -
News Global Pharmaceutical Industry Calls for Cooperation on Counterfeit Medicines
Global industry groups have teamed up to tackle the serious problem of counterfeiting. -
News US Health Secretary Announces New Public-private Partnerships to Fight HIV/Aids
Kathleen Sebelius said a collective response from both public and private organisations is needed to fight the HIV/Aids epidemic. -
News RegeneRx And Lee's Reach License Agreement for TB4-based Products
RegeneRx and Lee's Pharmaceuticals have announced a licensing agreement for RegeneRx's TB4-based products in China (including Hong Kong and Macau) and Taiwan. -
News Report Shows Strong M&A Activity for Healthcare IT Sector
M&A activity in the healthcare and pharmaceutical IT sector is robust, according to Berkery Noyes. -
News Investment in eClinical Trial Solutions Could Improve Efficiency, Report Says
GBI Research predicts an increase in demand for eClinical trial solutions over the coming years, with a particular focus on electronic data capture. -
News TPG Set to Buy Par Pharmaceuticals
Generic drug maker Par Pharmaceuticals has agreed to be bought for $1.9 billion by TPG. -
News BMS to Expand Puerto Rican Site
Bristol-Myers Squibb is expanding its Humacao facility in order to manufacture additional medicines on the island of Puerto Rico. -
News Global Medicines Spend to Reach Nearly $1.2Tr in 2016
The IMS Institute for Healthcare Informatics forecasts 5-7 per cent growth in the global market in 2016. -
News Takeda & Affymax Announce Supply Agreement
The agreement allows Fresenius Medical Care North America to purchase OMONTYS for use in U.S. centers within its organization and provides for discounts and rebates on the product, subject to certain requirements. -
News BMS Begins Tender Offer to Acquire US Biotech Amylin
Bristol-Myers Squibb is commencing a tender offer to acquire all outstanding shares of common stock in Amylin Pharmaceuticals. -
News Pharma Companies Team up with Academic Institutions for TB Drug Discovery
The TBDA partnership aims to produce new clinical drug candidates with the potential to treat TB within a month. -
News Quintiles Launches Go-to-market Service for Biopharma
Allume will help biopharmaceutical companies to bring their products to market more quickly and efficiently. -
News Swiss Manufacturer Siegfried Plans Production Plant in China
Siegfried plans to open a new production plant in Nantong, China. -
News Pfizer Accused of Delaying Generic Versions of Lipitor
Pfizer is being sued by five retailers over its alleged actions to delay sales of generic versions of Lipitor. -
News Indian Generics Policy Is Bad News for Big Pharma
Pharmaceutical giants will suffer as a result of India's decision to hand out free generic medicines to its entire population. -
News Amgen Completes Acquisition of KAI Pharmaceuticals
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals. -
News Medunik Canada & Orphan Europe Ink Deal
Under the distribution agreement, Medunik Canada receives the exclusive Canadian rights to market and distribute four important therapies. -
News Pharma Marketers Embracing Social Media
Websites such as Facebook and Twitter are increasingly being used by direct-to-consumer pharmaceutical marketing companies in markets where this type of advertising is allowed. -
News AstraZeneca Teams up with Cellworks to Find New TB Treatment
AstraZeneca and Cellworks have announced a Wellcome Trust-supported collaboration to speed up the design of new combination therapies for multi drug resistant TB. -
News HGS Rejects GSK Extension of Unsolicited Tender Offer
Human Genome Sciences has rejected GlaxoSmithKline's latest extension to its tender offer. -
News Bristol-Myers to Buy Diabetes Drug Maker Amylin for $5.3Bn
Bristol-Myers Squibb and Amylin Pharmaceuticals have announced that the global biopharmaceutical giant is set to acquire the diabetes drug maker for approximately $5.3 billion. -
News Argentina Proving Popular with CROs
A report by GBI Research has highlighted Argentina's increasing popularity as a cost-effective yet high-quality place to conduct clinical trials. -
News Scientists Find Easier Way to Make New Drug Compounds
Bristol Myers Squibb will employ a novel technique to develop and manufacture drugs. -
News Selvita & Orion Pharma Achieve a Research Milestone in Alzheimers Disease Program
Selvita is responsible for the discovery and Orion is responsible for the development and global commercialization. -
News Merck And AstraZeneca Amend Partnership, Agree Terms for Two More Years
Merck and AstraZeneca have amended their US partnership, giving the latter a 2014 buyout option. -
News 5 Minutes with Hao Gao, Scientist, R&D, Dow Wolff Cellulosics
Hao Gao, scientist, R&D, Dow Wolff Cellulosics, believes that customers seek new technologies and designer solutions for a competitive edge and his company is committed to delivering these kinds of tailored solutions. -
News FDA Approval of Generic ADHD Drug Hits Shire Shares
Actavis has received FDA approval for its generic version of Shire's Adderall XR, causing shares in the British drugmaker to plummet. -
News TaiGen & ZMC Sign Agreement for Antibiotic Nemonoxacin
TaiGen Biotechnology and Zhejiang Medicine Company have agreed terms for the broad-spectrum antibiotic nemonoxacin. -
News BRIC Markets Account for 20-30Pc of Pharma Companies' Profits
Cegedim's latest report highlights strategies to boost growth in China and other emerging markets. -
News Sales in China's Pharmaceutical Distribution Industry up 23Pc
China's Ministry of Commerce has published the latest figures on pharmaceutical distribution industry sales. -
News Quintiles to Establish HQ And Expand Lab Testing Capabilities in China
Quintiles is investing $14m in a new regional headquarters in Shanghai, as well as expanding its lab testing capabilities in China. -
News AstraZeneca Completes Ardea Merger
AstraZeneca has completed its takeover of biotechnology company Ardea Biosciences. -
News CellCentric & ZoBio Enter into Partnership to Develop Lead Compounds against Epigenetic Drug Targets
ZoBio will use its proprietary TINS technology to screen its fragment library against targets nominated by CellCentric. -
News Joint Call for Action to Alleviate Drug Shortages
An international collaboration is seeking to address drug shortages for patients with blood disorders. -
News Valeant Buys Oral Health Specialist OraPharma
Canadian drug maker Valeant has announced the acquisition of OraPharma. -
News Takeda to Cease Distribution of Pfizer Products in Japan
Takeda is to stop selling 13 Pfizer Inc drugs in Japan. -
News Small to Mid-sized Pharma Companies 'Turning to Cloud CRM Systems'
Cloud-based CRM systems offer smaller pharmaceutical companies a fast and cost-effective solution. -
News Human Genome Sciences Sets Bid Date of July 16th
Interested bidders have until July 16th to submit definitive proposals to acquire Human Genome Sciences. -
News OTC Pharmaceuticals Market to Reach $80.7Bn in 2014
The world market for over-the-counter (OTC) medicines will reach $80.7 billion in 2014, according to a new report from Visiongain. -
News Lilly Expands Partnership with Chinese Drugmaker Novast
Eli Lilly is increasing its investment in Chinese pharmaceutical company Novast Laboratories. -
News Cobra & Alligator Form Alliance for Monoclonal Antibody
Cobra Biologics and Alligator Bioscience have signed a manufacturing services and supply agreement for the production of monoclonal antibody drug product. -
News Anderson & Brecon Form Global Pharmaceutical Packaging Company
AndersonBrecon will provide packaging solutions for the pharmaceutical industry from 12 facilities across two continents. -
News Spectrum Pharmaceuticals Extends Tender Offer Period for Allos Therapeutics Shares
Spectrum and Allos have announced a further extension to the tender offer period for shares of Allos Therapeutics. -
News Public-private partnership aims to develop sustainable pharmaceuticals
A new research hub aims to develop sustainable alternatives to the finite materials used during pharmaceuticals manufacturing. -
News Bausch + Lomb Bolsters Product Portfolio with ISTA Acquisition
Bausch + Lomb has completed its acquisition of ISTA Pharmaceuticals. -
News Mexican Pharma Companies Represent Second-biggest Manufacturing Sector
Mexico is becoming an increasingly important emerging market for global pharmaceutical firms, according to research conducted by industry chamber Canifarma. -
News Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals
The alliance will be focused on complementing Cubists drug discovery programs with new lead compounds in the development of new anti-bacterial drugs. -
News GSK Extends Tender Offer for HGS
Human Genome Sciences has once again rejected GSK's unsolicited tender offer after the UK-based pharmaceutical group extended the deadline until June 29th. -
News UK Pharma Chief Expresses Concerns for Future of Medical Research
The chief executive of the ABPI has voiced fears about the UK government's focus on 'breakthrough' drug research. -
News OncoSec & VGXI Enter into Immunotherapy Drug Agreement
OncoSec Medical has chosen VGXI Inc as its manufacturing partner for DNA IL-12. -
News Dr Reddy's And Merck Announce Biosimilars Collaboration
Dr Reddy's Laboratories and Merck Serono will work together to develop cheaper versions of cancer biologics. -
News Takeda Completes Acquisition of URL Pharma
Takeda's wholly owned subsidiary, Takeda America Holdings, Inc., has completed its acquisition of URL Pharma, Inc. for an upfront payment of $800 million. -
News ShangPharma & Eli Lilly Celebrate 10 Years of Partnership
ShangPharma Corporation has celebrated the 10th anniversary of its partnership with Eli Lilly and Company. -
News US Has Nearly 1,000 Anti-cancer Medicines in Development
A new report highlights the efforts of biopharmaceutical companies to fight cancer. -
News Galapagos & Ono Pharmaceutical Sign Collaboration Agreement
The two firms have signed a collaboration agreement for the discovery of targets in the field of allergic diseases. -
News AptarGroup to Acquire Stelmi Group for $207M
AptarGroup is to acquire the Stelmi Group, a maker of elastomer primary packaging components for injectable drug delivery. -
News Pharmaceutical Companies Allocating More Money to Digital Marketing
A report by Cutting Edge Information has highlighted the growing importance of digital marketing in the pharmaceutical industry. -
News Pharmaceutical Companies Have 'Limited' Experience of REMS Plans
Best Practices' latest report looks at trends in supporting risk mitigation programmes in the pharmaceutical industry. -
News Bristol-Myers Squibb Announces Global Industry-academia Collaboration
The International Immuno-Oncology Network will work to improve scientists' understanding of ways to harness the immune system to fight cancer. -
News China's Pharmaceuticals Sales Force Levels Surpass US for First Time
China now has a larger pharmaceutical sales force than the US. -
News World Health Assembly Endorses GVAP
Following the approval by the World Health Assembly, the GVAP will be adapted for implementation at the regional and country level. -
News PPD Names New CEO
Pharmaceutical Product Development, LLC has announced that its board of directors has named David Simmons chairman and CEO. -
News India to Sign MoU with Japan to Facilitate Pharma Exports
Constant interaction with the Japanese local industry association will help the Indian players to understand their market needs and also help to synchronise India's regulatory standards with that of the Japanese. -
News Pharma Companies Urged to React to Changing Payment Landscape
Drug manufacturers that meet new expectations of value in healthcare will have a competitive advantage, says PwC. -
News Report Looks at Growing Need for Cold Chain Storage
Experts predict that four-fifths of major drug products will require cold chain storage and handling by 2016. -
News Osiris' Prochymal Becomes World's First Approved Stem Cell Drug
Prochymal has become the world's first approved stem cell drug. -
News India Emerges as Major Hub for API Sourcing
Many Indian API players are well ahead of other countries in filing of DMFs in US and CoS in Europe. With investments in R&D and focus on quality as well as cost, Indian companies have been able to maintain their position in the international market. -
News Avalanche & Lonza to Collaborate on Adeno-associated Viral Vectors
Avalanche and Lonza are partnering up to develop and manufacture AAV vectors for the treatment of eye diseases such as macular degeneration. -
News Human Genome Sciences Brands GSK Tender Offer 'Inadequate'
HGS has urged stockholders not to tender their shares to GSK following the pharmaceutical giant's 'inadequate' tender offer. -
News Breast Cancer Pipeline Remains Strong, Analysts Say
A new report from Frost & Sullivan has highlighted the unmet need for breast cancer therapies. -
News GSK to Fully Acquire Cellzome
GSK took an initial 19.98% stake in Cellzome in 2008 and will now purchase the remaining 80.02% shares in the company. -
News IPEC Foundation to Establish IPEC India
IPEC intends to play an instrumental role in sensitising the Indian excipient manufacturers and exporters about its guidelines which is globally accepted by top regulators across the world. -
News Arena & Eisai Expand Lorcaserin Marketing & Supply Agreement
Arena and Eisai have announced an expansion to their original marketing and supply agreement for weight-loss drug candidate lorcaserin. -
News Pharmaceuticals Industry Sees Spate of M&A Activity
Some $33 billion of M&A activity took place among pharmaceuticals companies in April. -
News GSK Commences Tender Offer to Acquire Human Genome Sciences
GSK has commenced an unsolicited tender offer to acquire all of the outstanding common shares of Human Genome Sciences at a price of $13 per share. -
News AMRI Posts First Quarter 2012 Results
The company's total revenue for the first quarter of 2012 was $53.7 million, a decrease of 6% compared to total revenue of $56.9 million reported in the first quarter of 2011. -
News BASF Acquires Equateq for Fatty Acids Portfolio
BASF says highly concentrated omega-3 fatty acids are a global growing market and increasing consumer awareness of the health benefits of omega-3 will see double-digit growth in the years to come. -
News Bayer Yakuhin & Santen Enter Agreement for Eylea Injections
Bayer Yakuhin and Santen will team up to promote Eylea in Japan. -
News Affymetrix & eBioscience Amend Definitive Merger Agreement
Under the terms of the amended agreement, Affymetrix will acquire eBioscience for $315 million in cash subject to usual adjustments. -
News NIH And Industry Team up to Find Uses for Abandoned Drugs
Pfizer, AstraZeneca and Lilly will make dozens of compounds available for the project. -
News Novartis to Acquire Dermatology Company Fougera
Sandoz, the generics division of Novartis, is to acquire dermatology specialist Fougera at a transaction value of $1.525 billion. -
News Sartorius Stedim Biotech Signs Sales Agreement with c-LEcta
The two firms have signed a worldwide sales and distribution agreement for c-LEctas proprietary Serratia marcescens nuclease for biopharmaceutical applications. -
News GSK & Yale Team up for Drug Discovery
GSK and Yale will work together to develop an entirely new class of drugs based on PROTACs technology. -
News Watson to Become Third Largest Global Generics Company Following Actavis Takeover
Watson Pharmaceuticals and Actavis Group have announced that Watson is buying the generic drugmaker. -
News NHS Restructuring May Affect UK Pharma
An expert has claimed that the NHS overhaul taking place in England will have a knock-on effect on the pharmaceutical industry. -
News Mergers & Acquisitions Activity 'Lower Than Expected' in 2011
The latest report from BioWorld reveals that M&A activity was more subdued than expected in 2011, while the number of biopharmaceutical collaborations declined. -
News Jazz Pharmaceuticals to Acquire EUSA Pharma
Jazz Pharmaceuticals and EUSA Pharma have announced that Jazz Pharmaceuticals has agreed to acquire the specialty pharmaceutical company for $650 million in cash and a potential $50 million milestone payment. -
News UK Pharma Industry to Benefit from First Cloud Service
BT's new cloud-based service could help to reduce research costs and accelerate the development of new drugs. -
News ARTES Announces Strategic Collaboration Deal for Vaccine Development
Under the terms of the long-term research collaboration ARTES is responsible for delivery of the production cell lines and processes to Crucell. -
News AstraZeneca to Acquire Ardea Biosciences
AstraZeneca is to acquire biotechnology firm Ardea Biosciences for $1.26 billion. The transaction is expected to complete in the second or third quarter of 2012. -
News Nestle to Buy Pfizer's Nutrition Business
Pfizer has agreed to sell its Pfizer Nutrition to Nestle for $11.85bn.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance